SlideShare a Scribd company logo
1 of 2
Download to read offline
 Have you tried?
o Non-pharmacologic (RICE, CBT, hot/cold)
o Scheduled Tylenol
o Tramadol
o NSAIDS (only in younger patients!!!)
Pharmacotherapy of Opioid
Analgesics
First – does my patient need an opioid?
Duration of Action
Opioid Equivalency Chart:
1
Alex Evans, PharmD, RPh
QUICK QUIZ!!
 Short-acting opioids:
o Morphine IR
o Oxycodone IR
o Hydrocodone (Vicodin, Lortab)
o Hydromorphone (Dilaudid)
o Codeine (Tylenol #3/4; Robitussin AC)
 Long-acting opioids: ONLY USE IN OPIOID
TOLERANT PATIENTS!
o MS Contin
o Fentanyl patches
o Oxycontin
 Characteristics of both: Methadone (not “extended
release” but has a long and variable half-life)
RC receives Tylenol 650mg TID
with no relief. The doctor then
decides to start
hydrocodone/APAP 5/500 (ii PO
q4hr prn pain) and the patient
needs about four doses a day (8
tabs). Is the patient opioid-tolerant
or opioid-naïve?
Opioid Tolerant: Has taken 60mg
of morphine equivalent for at least
a week.
 A 77-year old woman was prescribed Vicodin 5/500 four times/day for
sciatica and used it for a week. She was still complaining of pain so MD
prescribed fentanyl 50mcg/hr patch. She also used a heating pad. She
was found dead in her apartment two days after picking the
medication up.
 A 2-year old boy died after ingesting a fentanyl patch he got while
visiting his grandmother in the nursing home (happened Nov 2011).
 A hospital gives one dose of OxyContin to the incorrect patient in
2005. He died 12 hours later.
Medication errors involving long-acting opioids
 Respiratory depression (can be fatal)
 Constipation
 Nausea
 Itching
 Drowsiness/dizziness/confusion (increase the
risk for falls)
Adverse effects of ALL opioids
1. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm309742.htm
2. http://www.acpinternist.org/archives/2008/01/extra/pain_charts.pdf
3. “Tragic events with concentrated opiate oral solutions” Institute for safe medication practices. Accessed online September 24, 2012
at http://www.ismp.org/newsletters/ambulatory/archives/200807-1.asp
4. Grissinger M. Fentanyl transdermal patches: more protection needed for patients and their families. P and T 2009 Jul; 34(7):
343, 390. Accessed online September 24, 2012 at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799102/
5. List of error-prone abbreviations, symbols, and dose designations. Institute for safe medication practices. Accessed online
September 24, 2012 at http://www.ismp.org/tools/errorproneabbreviations.pdf.
6. “WHO’s pain ladder” The World Health Organization. Accessed online September 24, 2012 at
http://www.who.int/cancer/palliative/painladder/en/
7. Lehman D. “Jury orders hospital to pay in wrongful death lawsuit.” Post Star Nov 10, 2012. Accessed online September 24, 2012
at http://poststar.com/news/local/jury-orders-hospital-to-pay-in-wrongful-death-lawsuit/article_d2b060fe-e6be-11df-a23f-
001cc4c03286.html
8. “Proper disposal of fentanyl patches is critical to prevent accidental exposure” National Alert Network. Accessed online
September 24, 2012 at http://www.ismp.org/nan/files/nan-20120425.pdf
References
Long-acting
opioids should
NEVER be used in
opioid-naïve
patients!!!!
2
Remember – virtually
all opioids are controls
so we will need to get a
prescription. Request
them several days
before they are due for
a refill so we have time
to communicate with
the doctor!!
Options for NPO opioid-naïve patients that need opioids
 Roxanol (morphine) sublingually
 Oxycodone liquid sublingually
 Morphine IV or SCut
 Compounding pharmacy – can compound a variety of
dosage forms (suppositories, lollipops, creams)
Opioid Safety Tips
 Roxanol – always write the dose in MILLIGRAMS
rather than volume
 Unapproved abbreviations – MSO4; Oxy IR; SC (use
“SCut”); QD, QID, or QOD.
 Make sure we have ALL orders, regardless of who is
providing it (i.e. family, compounding pharmacy,
etc) so we can properly screen for drug interactions,
dose, etc.
 In particular, if opioids don’t scan let me know!!!!
Blake, 2 years old, died from ingesting a
fentanyl patch

More Related Content

Viewers also liked (12)

Capitulo33
Capitulo33Capitulo33
Capitulo33
 
Maintaining global freedom from rinderpest in Africa
Maintaining global freedom from rinderpest in AfricaMaintaining global freedom from rinderpest in Africa
Maintaining global freedom from rinderpest in Africa
 
Resumen delo que se ha instruido a la hermandad SOBRE LA CLAUSULA DE EXCEPCION
Resumen delo que se ha instruido a la hermandad SOBRE LA CLAUSULA DE EXCEPCIONResumen delo que se ha instruido a la hermandad SOBRE LA CLAUSULA DE EXCEPCION
Resumen delo que se ha instruido a la hermandad SOBRE LA CLAUSULA DE EXCEPCION
 
FY 13 Q3 Concern and Awareness Report
FY 13 Q3 Concern and Awareness ReportFY 13 Q3 Concern and Awareness Report
FY 13 Q3 Concern and Awareness Report
 
037
037037
037
 
Proceso de inscripcion psm
Proceso de inscripcion psmProceso de inscripcion psm
Proceso de inscripcion psm
 
Presentation shop
Presentation shopPresentation shop
Presentation shop
 
Filanthropia
FilanthropiaFilanthropia
Filanthropia
 
Curriculum investigation #2
Curriculum investigation #2Curriculum investigation #2
Curriculum investigation #2
 
1 1
1 11 1
1 1
 
LinkedIn Recruiter Expert
LinkedIn Recruiter ExpertLinkedIn Recruiter Expert
LinkedIn Recruiter Expert
 
Homework Powerpoint
Homework PowerpointHomework Powerpoint
Homework Powerpoint
 

Similar to AlexEvansOpioid Inservice

1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
herminaprocter
 

Similar to AlexEvansOpioid Inservice (20)

1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
 
Burn
BurnBurn
Burn
 
burn-181212040734.pdf on Management of burn Patients
burn-181212040734.pdf on Management of burn Patientsburn-181212040734.pdf on Management of burn Patients
burn-181212040734.pdf on Management of burn Patients
 
Nada Alkis' Master Thesis, Novo Nordisk & University of Copenhagen
Nada Alkis' Master Thesis, Novo Nordisk & University of CopenhagenNada Alkis' Master Thesis, Novo Nordisk & University of Copenhagen
Nada Alkis' Master Thesis, Novo Nordisk & University of Copenhagen
 
ARDS: An Evidence-based Update. By Mac Sweeney.
ARDS: An Evidence-based Update. By Mac Sweeney.ARDS: An Evidence-based Update. By Mac Sweeney.
ARDS: An Evidence-based Update. By Mac Sweeney.
 
Module C week 4
Module C week 4 Module C week 4
Module C week 4
 
Nursing Presentation on burns and its management .pdf
Nursing Presentation on burns and its management .pdfNursing Presentation on burns and its management .pdf
Nursing Presentation on burns and its management .pdf
 
case presentation on Osteoporosis
case presentation on  Osteoporosis case presentation on  Osteoporosis
case presentation on Osteoporosis
 
Open PSY EMERG 2.pdf
Open PSY EMERG 2.pdfOpen PSY EMERG 2.pdf
Open PSY EMERG 2.pdf
 
History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..History and overview of pharmacovigilance adverse event..
History and overview of pharmacovigilance adverse event..
 
Chapter 1: Medicines and vaccines
Chapter 1: Medicines and vaccinesChapter 1: Medicines and vaccines
Chapter 1: Medicines and vaccines
 
Herbal drug technology Unit IV PCI syllabus semester VI
 Herbal drug technology Unit IV PCI syllabus semester VI Herbal drug technology Unit IV PCI syllabus semester VI
Herbal drug technology Unit IV PCI syllabus semester VI
 
ARDS - An Evidence Based Update by Rob Mac Sweeney
ARDS -    An Evidence Based Update by Rob Mac SweeneyARDS -    An Evidence Based Update by Rob Mac Sweeney
ARDS - An Evidence Based Update by Rob Mac Sweeney
 
Alocado™ clinical study report dr angela ruban
Alocado™ clinical study report dr angela rubanAlocado™ clinical study report dr angela ruban
Alocado™ clinical study report dr angela ruban
 
Rad 104 hospital practice and care of patients 3 drugs & contrast 2016
Rad 104 hospital practice and care of patients 3  drugs & contrast 2016Rad 104 hospital practice and care of patients 3  drugs & contrast 2016
Rad 104 hospital practice and care of patients 3 drugs & contrast 2016
 
Toxic epidermal necrolysis
Toxic epidermal necrolysisToxic epidermal necrolysis
Toxic epidermal necrolysis
 
Orphan drugs
Orphan drugsOrphan drugs
Orphan drugs
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 
Opioid-Epidemic.pdf
Opioid-Epidemic.pdfOpioid-Epidemic.pdf
Opioid-Epidemic.pdf
 

AlexEvansOpioid Inservice

  • 1.  Have you tried? o Non-pharmacologic (RICE, CBT, hot/cold) o Scheduled Tylenol o Tramadol o NSAIDS (only in younger patients!!!) Pharmacotherapy of Opioid Analgesics First – does my patient need an opioid? Duration of Action Opioid Equivalency Chart: 1 Alex Evans, PharmD, RPh QUICK QUIZ!!  Short-acting opioids: o Morphine IR o Oxycodone IR o Hydrocodone (Vicodin, Lortab) o Hydromorphone (Dilaudid) o Codeine (Tylenol #3/4; Robitussin AC)  Long-acting opioids: ONLY USE IN OPIOID TOLERANT PATIENTS! o MS Contin o Fentanyl patches o Oxycontin  Characteristics of both: Methadone (not “extended release” but has a long and variable half-life) RC receives Tylenol 650mg TID with no relief. The doctor then decides to start hydrocodone/APAP 5/500 (ii PO q4hr prn pain) and the patient needs about four doses a day (8 tabs). Is the patient opioid-tolerant or opioid-naïve? Opioid Tolerant: Has taken 60mg of morphine equivalent for at least a week.
  • 2.  A 77-year old woman was prescribed Vicodin 5/500 four times/day for sciatica and used it for a week. She was still complaining of pain so MD prescribed fentanyl 50mcg/hr patch. She also used a heating pad. She was found dead in her apartment two days after picking the medication up.  A 2-year old boy died after ingesting a fentanyl patch he got while visiting his grandmother in the nursing home (happened Nov 2011).  A hospital gives one dose of OxyContin to the incorrect patient in 2005. He died 12 hours later. Medication errors involving long-acting opioids  Respiratory depression (can be fatal)  Constipation  Nausea  Itching  Drowsiness/dizziness/confusion (increase the risk for falls) Adverse effects of ALL opioids 1. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm309742.htm 2. http://www.acpinternist.org/archives/2008/01/extra/pain_charts.pdf 3. “Tragic events with concentrated opiate oral solutions” Institute for safe medication practices. Accessed online September 24, 2012 at http://www.ismp.org/newsletters/ambulatory/archives/200807-1.asp 4. Grissinger M. Fentanyl transdermal patches: more protection needed for patients and their families. P and T 2009 Jul; 34(7): 343, 390. Accessed online September 24, 2012 at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799102/ 5. List of error-prone abbreviations, symbols, and dose designations. Institute for safe medication practices. Accessed online September 24, 2012 at http://www.ismp.org/tools/errorproneabbreviations.pdf. 6. “WHO’s pain ladder” The World Health Organization. Accessed online September 24, 2012 at http://www.who.int/cancer/palliative/painladder/en/ 7. Lehman D. “Jury orders hospital to pay in wrongful death lawsuit.” Post Star Nov 10, 2012. Accessed online September 24, 2012 at http://poststar.com/news/local/jury-orders-hospital-to-pay-in-wrongful-death-lawsuit/article_d2b060fe-e6be-11df-a23f- 001cc4c03286.html 8. “Proper disposal of fentanyl patches is critical to prevent accidental exposure” National Alert Network. Accessed online September 24, 2012 at http://www.ismp.org/nan/files/nan-20120425.pdf References Long-acting opioids should NEVER be used in opioid-naïve patients!!!! 2 Remember – virtually all opioids are controls so we will need to get a prescription. Request them several days before they are due for a refill so we have time to communicate with the doctor!! Options for NPO opioid-naïve patients that need opioids  Roxanol (morphine) sublingually  Oxycodone liquid sublingually  Morphine IV or SCut  Compounding pharmacy – can compound a variety of dosage forms (suppositories, lollipops, creams) Opioid Safety Tips  Roxanol – always write the dose in MILLIGRAMS rather than volume  Unapproved abbreviations – MSO4; Oxy IR; SC (use “SCut”); QD, QID, or QOD.  Make sure we have ALL orders, regardless of who is providing it (i.e. family, compounding pharmacy, etc) so we can properly screen for drug interactions, dose, etc.  In particular, if opioids don’t scan let me know!!!! Blake, 2 years old, died from ingesting a fentanyl patch